Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Announces Its Intent to Purchase in...

0
The rapid spread of coronavirus has been a wakeup call for many pharmaceutical companies on how quickly they can make vaccines for emerging infectious...

The FDA Endorses a Phase 1/2 Clinical Trial of NT219 from...

0
Kitov Pharma (NASDAQ:KTOV) has had a successful journey in advancing its first-in-class therapies, which overcome tumor immune evasion. Its long-lasting treatments for people with...

Popular News

TG Therapeutics Inc. (NASDAQ:TGTX) Reports Phase 3 GENUINE Study Results Evaluating...

0
TG Therapeutics Inc. (NASDAQ:TGTX) has announced final GENUINE third Phase study results for the evaluation of ublituximab’s combination and ibrutinb relative to using ibrutinib...

STAY CONNECTED

20,205FansLike
67,939FollowersFollow
32,600SubscribersSubscribe

MAKE IT MODERN

LATEST REVIEWS

Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV) Receive The FDA’s Response After...

0
Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV) recently announced that it received the Food and Drug Administration’s (FDA) complete response letter regarding its New Drug...

MAKE IT MODERN

PERFORMANCE TRAINING

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) CEO Presents Update On Mino-Lok Study At Life Sciences Investors...

0
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) has announced that its CEO Myron Holubiak will offer a virtual presentation at the Life Sciences Investors Forum, including an...
HFT

High-frequency trading during the holiday season

0
There always exists a conflict between investors and traders. One extracts inefficiencies in transactions while the other attempts to define value. Technological...

The FDA Endorses a Phase 1/2 Clinical Trial of NT219 from Kitov Pharma (NASDAQ:KTOV)

0
Kitov Pharma (NASDAQ:KTOV) has had a successful journey in advancing its first-in-class therapies, which overcome tumor immune evasion. Its long-lasting treatments for people with...

The Coronavirus Coping Portfolio (QDEL, GILD, QBIO, CYDY)

0
The COVID-19 pandemic has forced a dramatic realignment of social, cultural, and economic agendas because, in all cases, the healthcare issue has...

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) Finalizes RESOLVE-1 Third Phase Lenabasum Study In Systemic Sclerosis

0
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) has announced that the last subject in its RESOLVE-1 third phase lenabasum study for systemic sclerosis treatment has competed...

MAKE IT MODERN

POPULAR

.td-post-views{ display: none !important; }